** Analysts at Jefferies upgrade price target on Australia's
Sonic Healthcare SHL.AX to A$29.35/shr from A$28.90/shr
** SHL acquires Switzerland's Dr. Risch Group for CHF117 mln
($131.25 mln)
** Brokerage sees FY25 EBITDA margins at 27.3% for SHL's
Switzerland's division
** "SHL continues to generate cash - this raises the
possibility of further corporate activity over the medium term,
which may be seen positively" - Jefferies
** Five of 16 analysts rate the stock "buy" or higher, seven
"hold" and four "sell" or lower; their median PT is A$30.87 –
LSEG data
** SHL stock down 14.9% YTD, as of last close
($1 = 0.8914 Swiss francs)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))